# Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma

> **NCT02616926** · NA · UNKNOWN · sponsor: **First Affiliated Hospital, Sun Yat-Sen University** · enrollment: 538 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** Hepatic resection
- **PROCEDURE:** TACE
- **PROCEDURE:** RFA

## Key facts

- **NCT ID:** NCT02616926
- **Lead sponsor:** First Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2018-07
- **Final completion:** 2021-07
- **Target enrollment:** 538 (ESTIMATED)
- **Last updated:** 2015-12-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02616926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02616926, "Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02616926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*